Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
Titel:
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
Auteur:
Sharpe, Benjamin P. Hayden, Annette Manousopoulou, Antigoni Cowie, Andrew Walker, Robert C. Harrington, Jack Izadi, Fereshteh Breininger, Stella P. Gibson, Jane Pickering, Oliver Jaynes, Eleanor Kyle, Ewan Saunders, John H. Parsons, Simon L. Ritchie, Alison A. Clarke, Philip A. Collier, Pamela Mongan, Nigel P. Bates, David O. Yacqub-Usman, Kiren Garbis, Spiros D. Walters, Zoƫ Rose-Zerilli, Matthew Grabowska, Anna M. Underwood, Timothy J.